AbstractThe management of infections in haematology is dictated by the patient's type of acquired or induced immune deficiency (neutropenia, deficiency in cell-mediated or antibody-mediated immunity), and findings from clinical examination, laboratory studies, or morphologic investigations. The CT scan dominates in the initial management and follow-up of these patients, since clinical features very often appear to be non-specific. The radiologist's role is to guide the clinician towards a specific diagnosis such as aspergillosis or pneumocystosis, or to point them towards a non-infectious cause: tumour localisation, hypervolaemia, bronchiolitis obliterans suggestive of GVH disease, drug toxicity, or embolism
SummaryObjectivesThe identification of the specific pathogen responsible for a respiratory infection...
Baseline chest computed tomography (BCT) in high-risk hematology patients allows for the early diagn...
AbstractThe European Organization for Research and Treatment of Cancer and the Mycosis Study Group (...
AbstractThe management of infections in haematology is dictated by the patient's type of acquired or...
AbstractCT-guided transparietal lung biopsy in imaging makes it possible to find the pathogenic agen...
AbstractIn haematological malignancies, the development of lung disease is a common source of signif...
Infectious complications are an important cause of morbidity and mortality in patients with hematol...
The definition of pulmonary fungal infections (PFI) according to the EORTC-MSG criteria may lack dia...
AbstractIntroductionManagement of pulmonary disease in immunodepressed patients requires a clear dia...
Background : Chest infection is the major cause of morbidity and mortality among patients with haema...
Background. Detection of serum galactomannan (GM) antigen and presence of the halo sign on a pulmona...
Fever is the principle sign of infection in neutropenic patient and frequently may be the only evid...
Pulmonary complications affect up to 40% of patients with severe neutropenia lasting for more than 1...
To assess whether the type of immune suppression in patients with hematologic malignancies affects t...
BACKGROUND: Routine chest X-ray (CXR) is recommended for neutropenic fever (NF) management however i...
SummaryObjectivesThe identification of the specific pathogen responsible for a respiratory infection...
Baseline chest computed tomography (BCT) in high-risk hematology patients allows for the early diagn...
AbstractThe European Organization for Research and Treatment of Cancer and the Mycosis Study Group (...
AbstractThe management of infections in haematology is dictated by the patient's type of acquired or...
AbstractCT-guided transparietal lung biopsy in imaging makes it possible to find the pathogenic agen...
AbstractIn haematological malignancies, the development of lung disease is a common source of signif...
Infectious complications are an important cause of morbidity and mortality in patients with hematol...
The definition of pulmonary fungal infections (PFI) according to the EORTC-MSG criteria may lack dia...
AbstractIntroductionManagement of pulmonary disease in immunodepressed patients requires a clear dia...
Background : Chest infection is the major cause of morbidity and mortality among patients with haema...
Background. Detection of serum galactomannan (GM) antigen and presence of the halo sign on a pulmona...
Fever is the principle sign of infection in neutropenic patient and frequently may be the only evid...
Pulmonary complications affect up to 40% of patients with severe neutropenia lasting for more than 1...
To assess whether the type of immune suppression in patients with hematologic malignancies affects t...
BACKGROUND: Routine chest X-ray (CXR) is recommended for neutropenic fever (NF) management however i...
SummaryObjectivesThe identification of the specific pathogen responsible for a respiratory infection...
Baseline chest computed tomography (BCT) in high-risk hematology patients allows for the early diagn...
AbstractThe European Organization for Research and Treatment of Cancer and the Mycosis Study Group (...